Chris Saunders
About Chris Saunders
Chris Saunders is the Senior Director of Rare Disease Marketing at ANI Pharmaceuticals, Inc., where he has worked since 2023. He has extensive experience in pharmaceutical marketing, having held various leadership roles at companies such as Shire, Akili Interactive, and Merck.
Current Role at ANI Pharmaceuticals
Chris Saunders serves as the Senior Director of Rare Disease Marketing at ANI Pharmaceuticals, Inc. since 2023. His role is based in Princeton, New Jersey, where he focuses on marketing strategies for rare diseases. This position involves overseeing marketing initiatives and collaborating with cross-functional teams to enhance product visibility and market penetration.
Previous Experience at Shire
Chris Saunders has extensive experience at Shire, where he held multiple positions over several years. He worked as a Senior Product Manager and Product Manager for Intuniv and Dyatrana from 2006 to 2010. He later served as the Senior Director, US Launch Lead for Internal Medicine & Oncology for six months in 2017. Additionally, he was the Launch Lead/Product Director for Vyvanse in the Adult Binge Eating Disorder indication from 2012 to 2015 and the Senior Director, US Marketing Lead for Neuroscience from 2015 to 2017.
Leadership Roles in Marketing
In addition to his tenure at Shire, Chris Saunders held leadership positions in marketing at various organizations. He was the Vice President of Marketing for Akili Interactive, focusing on ADHD from 2018 to 2019. He also served as Chief Commercial Officer at Atentiv LLC from 2020 to 2021 and briefly at Metis Minds in 2022. His roles involved developing marketing strategies and leading product launches in the healthcare sector.
Educational Background
Chris Saunders earned a Bachelor of Science in Mechanical Engineering from Lafayette College, where he studied from 1987 to 1991. He later obtained a Master of Business Administration from Emory University - Goizueta Business School, completing his studies from 1996 to 1998. His educational background combines technical knowledge with business acumen, which supports his career in pharmaceutical marketing.
Notable Achievements in Product Launches
Chris Saunders has a track record of successful product launches in the pharmaceutical industry. He played a key role in launching INTUNIV, a brand that generated $500 million in revenue in 2009. Additionally, he developed a go-to-market strategy for the first FDA-cleared prescription video game designed to treat ADHD and led the expansion of Vyvanse's Binge Eating Disorder indication into international markets.